Quantitative structure-activity relationship studies of a series of sulfa drugs as inhibitors of Pneumocystis carinii dihydropteroate synthetase

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1454-1458

  Johnson, Theresa ^a   Khan, Ikhlas A ^a,b   Avery, Mitchell A ^a,b   Grant, Juliana ^c   Meshnick, Steven R ^c  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; DIFLUORODINITROPHENYLSULFONE; DIHYDROPTEROATE SYNTHASE; GLYOXALDAPSONE; NSC 107328; NSC 142656; NSC 163977; NSC 205491; NSC 270146; NSC 279282; NSC 303757; NSC 308795; NSC 355394; NSC 74428; RO 211182; RO 52928; RO 55615; RO 72844; SULFANILAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CALCULATION; ENZYME INHIBITION; MODEL; NONHUMAN; PARTITION COEFFICIENT; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS;

EID: 0031834746     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1454     Document Type: Article

References (15)

1. Anand, N. 1996. Sulfonamides and sulfones, p. 551-561. In M. E. Wolff (ed.), Burger's medicinal chemistry and drug discovery, vol. 2. John Wiley & Sons, Inc., New York, N.Y.
2. Basak, A. K., and S. K. Mazumdar. 1987. Structure of N′-(6-methoxy-3-pyridazinyl)sulfanilamide (sulfamethoxypyridazine). Acta Crystallogr. Sect. C 43:735-738.
3. Columbia University. 1995. MacroModel, version 4.5. Department of Chemistry, Columbia University, New York, N.Y.
4. Cramer, R. D., D. E. Patterson, and J. Bunce. 1988. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 110:5959-5967.
5. Edman, J. C., J. A. Kovacs, and H. Masur. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519-522.
6. Hansch, C., and A. Leo. 1979. Substituent constants for correlation analysis in chemistry and biology. John Wiley & Sons, Inc., New York, N.Y.
7. Hong, Y.-L., P. A. Hossler, D. H. Calhoun, and S. R. Meshnick. 1995. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob. Agents Chemother. 39:1756-1763.
8. Kaminski, J. J. 1994. Computer-assisted drug design and selection. Adv. Drug Delivery Rev. 14:331-337.
9. Kim, K. H. 1995. Comparative molecular field analysis (CoMFA), p. 291-331. In P. M. Dean (ed.), Molecular Similarity in Drug Design. Blackie, Glasgow, United Kingdom.
10. Nicklaus, M. C., G. W. A. Milne, and T. R. J. Burke. 1992. OSAR of conformationally flexible molecules: comparative molecular field analysis of protein-tyrosine kinase inhibitors. J. Comput.-Aided Mol. Des. 6:487-504.
11. Oxford Molecular Ltd. 1995. Tsar, version 2.4. Oxford Molecular Ltd., Magdalen Centre, Oxford, England.
12. Safrin, S., D. M. Finkelstein, J. Feinberg, P. Frame, G. Simpson, A. Wu, T. Cheung, R. Soeiro, P. Hojczyck, and J. R. Black. 1996. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. Ann. Intern. Med. 124:792-802.
13. Simonds, R. J., W. T. Hughes, J. Feinberg, and T. R. Navin. 1995. Preventing Pneumocystis carinii pneumonia in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21(Suppl. 1):S44-S48.
14. Tong, W., E. R. Collantes, Y. Chen, and W. J. Welsh. 1996. A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors. J. Med. Chem. 39:380-387.
15. Tripos Associates. 1995. Sybyl, version 6.2. Tripos Associates. St. Louis, Mo.